Cellular immunity against DNA tumour viruses: possibilities for peptide-based vaccines and immune escape.
Toes
R E
RE
Department of Immunohematology and Blood Bank, University Hospital, Leiden, The Netherlands.
Feltkamp
M C
MC
Ressing
M E
ME
Vierboom
M P
MP
Blom
R J
RJ
Brandt
R M
RM
Hartman
M
M
Offringa
R
R
Melief
C J
CJ
Kast
W M
WM
D000818:Animals; D000957:Antigens, Viral, Tumor / Q000302:isolation & purification; D004263:DNA Tumor Viruses / Q000276:immunology*; D000939:Epitopes / Q000302:isolation & purification; D006801:Humans; D007111:Immunity, Cellular; D007167:Immunotherapy; D016219:Immunotherapy, Adoptive; D051379:Mice; D009856:Oncogene Proteins, Viral / Q000276:immunology; D050725:Papillomavirus E7 Proteins; D010455:Peptides / Q000276:immunology; D012097:Repressor Proteins; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D014412:Tumor Virus Infections / Q000276:immunology / Q000517:prevention & control / Q000628:therapy; D014614:Vaccines, Synthetic / Q000302:isolation & purification
D000957:Antigens, Viral, Tumor; C068651:E6 protein, Human papillomavirus type 16; D000939:Epitopes; D009856:Oncogene Proteins, Viral; D050725:Papillomavirus E7 Proteins; D010455:Peptides; D012097:Repressor Proteins; D014614:Vaccines, Synthetic; C059731:oncogene protein E7, Human papillomavirus type 16